Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance

被引:30
作者
Metcalfe, John Z. [1 ]
Streicher, Elizabeth [2 ,3 ]
Theron, Grant [2 ,3 ]
Colman, Rebecca E. [4 ]
Allender, Christopher [5 ]
Lemmer, Darrin [5 ]
Warren, Rob [2 ,3 ]
Engelthaler, David M. [5 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Rm 5K1, San Francisco, CA 94110 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Tygerberg, South Africa
[4] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA
[5] Translat Genom Res Inst, Flagstaff, AZ USA
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
next-generation sequencing; Sanger sequencing; drug-resistant tuberculosis; diagnostics; DRUG-RESISTANCE; FLUOROQUINOLONE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; HETERO-RESISTANCE; GENOMIC ANALYSIS; SOUTH-AFRICA; HETERORESISTANCE; SUSCEPTIBILITY; MUTATIONS; DIAGNOSIS;
D O I
10.1164/rccm.201703-0556OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays. Objectives: To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations. Methods: We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group). Measurements and Main Results: Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (< 5%) subpopulations (n = 3/66) across both groups. Conclusions: Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 50 条
  • [21] Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
    Ismail, Nabila
    Riviere, Emmanuel
    Limberis, Jason
    Huo, Stella
    Metcalfe, John Z.
    Warren, Rob M.
    Van Rie, Annelies
    LANCET MICROBE, 2021, 2 (11): : E604 - E616
  • [22] A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
    Miotto, Paolo
    Tessema, Belay
    Tagliani, Elisa
    Chindelevitch, Leonid
    Starks, Angela M.
    Emerson, Claudia
    Hanna, Debra
    Kim, Peter S.
    Liwski, Richard
    Zignol, Matteo
    Gilpin, Christopher
    Niemann, Stefan
    Denkinger, Claudia M.
    Fleming, Joy
    Warren, Robin M.
    Crook, Derrick
    Posey, James
    Gagneux, Sebastien
    Hoffner, Sven
    Rodrigues, Camilla
    Comas, Inaki
    Engelthaler, David M.
    Murray, Megan
    Alland, David
    Rigouts, Leen
    Lange, Christoph
    Dheda, Keertan
    Hasan, Rumina
    Ranganathan, Uma Devi K.
    McNerney, Ruth
    Ezewudo, Matthew
    Cirillo, Daniela M.
    Schito, Marco
    Koser, Claudio U.
    Rodwell, Timothy C.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (06)
  • [23] Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: Phenotypic and genotypic methods
    Miyata, Marcelo
    Pavan, Fernando Rogerio
    Sato, Daisy Nakamura
    Marino, Leonardo Biancolino
    Hirata, Mario Hiroyuki
    Cardoso, Rosilene Fressati
    Fiuza de Melo, Fernando Augusto
    Zanelli, Cleslei Fernando
    Fujimura Leite, Clarice Queico
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (06) : 456 - 459
  • [24] Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea
    Jeon, Se-Mi
    Park, Sanghee
    Lim, Na-Ra
    Lee, Noori
    Jung, Jihee
    Sung, Nackmoon
    Kim, Seonghan
    ANTIBIOTICS-BASEL, 2023, 12 (08):
  • [25] Recent updates on drug resistance in Mycobacterium tuberculosis
    Singh, R.
    Dwivedi, S. P.
    Gaharwar, U. S.
    Meena, R.
    Rajamani, P.
    Prasad, T.
    JOURNAL OF APPLIED MICROBIOLOGY, 2020, 128 (06) : 1547 - 1567
  • [26] Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs
    Consuelo Garzon, Maria
    Yorledy Angee, Dailyn
    Llerena, Claudia
    Leticia Orjuela, Dora
    Ernesto Victoria, Jorge
    BIOMEDICA, 2008, 28 (03): : 319 - 326
  • [27] Perchlozone Resistance in Clinical Isolates of Mycobacterium tuberculosis
    Ushtanit, Anastasia
    Mikhailova, Yulia
    Krylova, Ludmila
    Grigorash, Dmitry
    Makarova, Marina
    Safonova, Svetlana
    Zimenkov, Danila
    ANTIBIOTICS-BASEL, 2023, 12 (03):
  • [28] Genomic markers of drug resistance in Mycobacterium tuberculosis populations with minority variants
    Zhang, Xiaomei
    Lam, Connie
    Martinez, Elena
    Sim, Eby
    Crighton, Taryn
    Marais, Ben J.
    Sintchenko, Vitali
    JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (10)
  • [29] Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates
    Sun, Z.
    Zhang, J.
    Song, H.
    Zhang, X.
    Li, Y.
    Tian, M.
    Liu, Y.
    Zhao, Y.
    Li, C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (11) : 1436 - 1441
  • [30] Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance
    Wang, Luqi
    Yang, Jinghui
    Chen, Liang
    Wang, Weibing
    Yu, Fangyou
    Xiong, Haiyan
    EPIDEMIOLOGY & INFECTION, 2022, 150